As many of our clients are aware, the FDA continues to modernize its import review process. One of the most significant changes over the past year has been the implementation of the FDA ImportShield Program (FISP), a centralized system designed to review FDA-regulated imports more efficiently and consistently across the United States.
Because this change affects how FDA reviews and communicates regarding imported products, I wanted to share a few key points that may help you better understand what to expect when importing FDA-regulated commodities.
Link: https://www.fda.gov/media/187855/download
Historically, FDA entry reviews were often handled by personnel assigned to specific ports of entry. Under the ImportShield Program, FDA has centralized much of this review process by utilizing specialized national review teams that can evaluate shipments entering through any port in the country.
The goal is to improve consistency, enhance FDA’s ability to identify higher-risk shipments, and streamline the review process for compliant imports.
For importers, this means that an FDA review may no longer be handled by someone physically located at the port where the shipment arrives.
In practical terms, many communications and document reviews that were previously managed at the local level are now routed through centralized FDA teams.
As a result, importers may notice changes in:
While the overall goal is to improve efficiency, understanding the process can help avoid unnecessary delays.
FDA strongly encourages importers and brokers to utilize the Import Trade Auxiliary Communication System (ITACS).
ITACS allows the trade community to:
In many situations, FDA prioritizes documents submitted through ITACS over those submitted through other communication channels.
For that reason, we recommend ensuring that requested documentation is uploaded promptly and completely whenever possible.
Generally, ImportShield handles entries that are:
However, once a shipment progresses to a more advanced stage such as:
communications are often transferred to FDA Import Operations or Compliance personnel assigned to the specific case.
One of the most effective ways to facilitate a smooth FDA review is by ensuring that entry information is accurate from the start.
We recommend paying close attention to:
FDA may request:
Having these documents readily available can significantly reduce response times.
When FDA requests information, timely and complete responses are critical. Submitting all relevant documents together often helps reviewers complete their assessment more efficiently than receiving information in multiple separate submissions.
As FDA continues to refine ImportShield, importers should expect the agency to rely more heavily on centralized reviews and electronic communications.
At J.O. Alvarez, Inc., we are closely monitoring these developments and assisting our clients with FDA entry reviews, document requests, FSVP compliance, Prior Notice requirements, and other FDA-related import matters.
If your company imports food, beverages, dietary supplements, cosmetics, medical devices, or other FDA-regulated products and you have questions regarding ImportShield or FDA entry processing, our team is available to help.
As always, our goal is to keep your shipments moving while helping you remain compliant with FDA and CBP requirements.
If you would like additional information regarding FDA ImportShield or have questions about a specific shipment, please feel free to contact our Compliance Team.
Disclaimer: The information contained in this article is provided for general informational purposes only and reflects our current understanding of FDA ImportShield procedures at the time of publication. Regulatory requirements, agency policies, and operational procedures may change without notice. This article should not be construed as legal, regulatory, or compliance advice. Importers remain responsible for ensuring compliance with all applicable FDA, CBP, and other government agency requirements. For guidance regarding a specific shipment or compliance matter, please consult with your customs broker, legal counsel, or qualified compliance professional.
Copyright © 2026 J.O. Alvarez, Incorporated. All rights reserved.
Website Design & Development by Gibson Design